Chapter Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells

Biomarkers offer a way to speed up medical research by shedding light on the physiopathological mechanisms of disease. Furthermore, biomarkers are considered invaluable tools for monitoring disease progression, prognosis, and response to drugs, especially in clinical trials, where they can be used t...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
1. autor: Hall, Vanessa J.
Format: Online
Język:angielski
Wydane: InTechOpen 2021
Hasła przedmiotowe:
Dostęp online:ONIX_20210602_10.5772/63521_259
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
_version_ 1869523137004044288
author Hall, Vanessa J.
author_browse Hall, Vanessa J.
author_facet Hall, Vanessa J.
author_sort Hall, Vanessa J.
collection Directory of Open Access Books
description Biomarkers offer a way to speed up medical research by shedding light on the physiopathological mechanisms of disease. Furthermore, biomarkers are considered invaluable tools for monitoring disease progression, prognosis, and response to drugs, especially in clinical trials, where they can be used to assess the efficacy, efficiency, and side effects of novel drugs.
format Online
id doab-20.500.12854ir-70616
institution Directory of Open Access Books
language eng
publishDate 2021
publishDateRange 2021
publishDateSort 2021
publisher InTechOpen
publisherStr InTechOpen
record_format ojs
spelling doab-20.500.12854ir-706162024-03-31T22:43:30Z Chapter Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells Hall, Vanessa J. biomarker, rare disease, genetic disease, genomics, transcriptomics, proteomics thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology Biomarkers offer a way to speed up medical research by shedding light on the physiopathological mechanisms of disease. Furthermore, biomarkers are considered invaluable tools for monitoring disease progression, prognosis, and response to drugs, especially in clinical trials, where they can be used to assess the efficacy, efficiency, and side effects of novel drugs. 2021-02-10T12:58:18Z 2021-06-02T10:07:47Z 2016 chapter ONIX_20210602_10.5772/63521_259 https://library.oapen.org/handle/20.500.12657/49145 https://directory.doabooks.org/handle/20.500.12854/70616 eng open access image/jpeg image/jpeg n/a n/a https://library.oapen.org/bitstream/20.500.12657/49145/1/50762.pdf https://library.oapen.org/bitstream/20.500.12657/49145/1/50762.pdf InTechOpen 10.5772/63521 10.5772/63521 035ecc65-6737-43cf-a13a-6bdf67ce01f4 open access
spellingShingle biomarker, rare disease, genetic disease, genomics, transcriptomics, proteomics
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
Hall, Vanessa J.
Chapter Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells
title Chapter Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells
title_full Chapter Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells
title_fullStr Chapter Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells
title_full_unstemmed Chapter Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells
title_short Chapter Modelling Neurodegenerative Diseases Using Human Pluripotent Stem Cells
title_sort chapter modelling neurodegenerative diseases using human pluripotent stem cells
topic biomarker, rare disease, genetic disease, genomics, transcriptomics, proteomics
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
topic_facet biomarker, rare disease, genetic disease, genomics, transcriptomics, proteomics
thema EDItEUR::M Medicine and Nursing::MJ Clinical and internal medicine::MJC Diseases and disorders::MJCL Oncology
url ONIX_20210602_10.5772/63521_259
work_keys_str_mv AT hallvanessaj chaptermodellingneurodegenerativediseasesusinghumanpluripotentstemcells